What is Neurobiological Technologies, Inc.'s annual revenue?

Neurobiological Technologies, Inc. (NTII) reported annual revenue of $26.0M in its most recent fiscal year.

What is Neurobiological Technologies, Inc.'s net profit?

Neurobiological Technologies, Inc. (NTII) reported net profit of $3.0M in its most recent fiscal year.

What is NTII EV/EBITDA?

Neurobiological Technologies, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.57.

OTC · Financial Statements

Neurobiological Technologies, Inc. (NTII) Financial Statements

$0.00 OTC: NTII Market Cap $2702

Neurobiological Technologies, Inc. most recently reported annual revenue of $26.0M, net profit of $3.0M, revenue has compounded at 54.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2005	2006	2007	2008	2009
Revenue	$12.0M	$18.0M	$15.0M	$26.0M	—
Operating Profit	$-28.0M	$-16.0M	$-17.0M	$3.0M	—
Net Profit	$-28.0M	$-14.0M	$-16.0M	$3.0M	—
EPS	$-6.86	$-3.26	$-0.84	$0.12	—
Op Margin	-226.4%	-88.3%	-113.1%	13.3%	—

Balance Sheet (USD)

Metric	2005	2006	2007	2008	2009
Total Assets	$22.0M	$11.0M	$43.0M	$25.0M	$3.0M
Total Liabilities	$34.0M	$33.0M	$23.0M	$1.0M	$1.0M
Cash	$10.0M	$6.0M	$28.0M	$8.0M	$2.0M
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2005	2006	2007	2008	2009
Operating Cash Flow	$9.0M	$-13.0M	$-21.0M	$-16.0M	—
Investing Cash Flow	$-1.0M	$2.0M	$-12.0M	$-3.0M	—
Financing Cash Flow	$0	$0	$0	$0	—
Net Cash Flow	$9.0M	$-4.0M	$22.0M	$-20.0M	—
Free Cash Flow	$9.0M	$-13.0M	$-21.0M	$-16.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.57
FCF Yield	-608105.11%
Quick Ratio	35.34
Interest Coverage	0.00
Return 1Y	0.00%
Return 3Y	0.00%
Return 5Y	—

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

NTII Overview NTII Dividend Run Stock Screener